Micronucleated erythrocyte frequency in control and azidothymidine-treated Tk+/+, Tk+/− and Tk−/− mice

This publication has 25 references indexed in Scilit:

• Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs
  Toxicology and Applied Pharmacology, 2004
• Analysis of mutations in the Tk gene of Tk+/− mice treated as neonates with 3′-azido-3′-deoxythymidine (AZT)
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
• Genetic damage detected in CD‐1 mouse pups exposed perinatally to 3′‐azido‐3′‐deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment
  Environmental and Molecular Mutagenesis, 2004
• Frequency of Tk and Hprt lymphocyte mutants and bone marrow micronuclei in B6C3F1/Tk+/- mice treated neonatally with zidovudine and lamivudine
  Carcinogenesis: Integrative Cancer Research, 2002
• Zidovudine
  Pediatric Drugs, 2002
• Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine
  Mutagenesis, 2000
• Nonclinical Toxicology Studies with Zidovudine: Genetic Toxicity Tests and Carcinogenicity Bioassays in Mice and Rats
  Fundamental and Applied Toxicology, 1996
• Induction of micronuclei by low doses of azidothymidine (AZT)
  Mutation Research/Genetic Toxicology, 1996
• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
  New England Journal of Medicine, 1994
• Induction of micronuclei in mouse bone marrow cells: An evaluation of nucleoside analogues used in the treatment of AIDS
  Environmental and Molecular Mutagenesis, 1991